<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2021</year>
    <pub-dates>
     <date>2021-09-22</date>
    </pub-dates>
   </dates>
   <doi>10.17691/stm2021.13.4.07</doi>
   <abstract>Imperfection of cytological diagnostics of cervical cancer has prompted the search for alternative methods of pathology detection.&#13;
&#13;
The aim of the study was to evaluate the effectiveness of inflammatory proteins as molecular markers in the diagnosis of cervical oncopathology.&#13;
&#13;
Materials and Methods. A prospective controlled trial was conducted with three groups of women: group 1 (n=13)- with precancerous pathology (cervical intraepithelial neoplasia of grade III); group 2 (n=49) - patients with cervical cancer; group 3, control (n=13) - gynecologically healthy women (mean age - 30.0 +/- 4.4 years).&#13;
&#13;
The material for the study was cervical epithelium, which was taken according to the standard technique using a cytobrush from the junction zone of cervical. The levels of inflammatory proteins (SAA, ICAM-1, VCAM-1, and sCD27) in the cervical epithelium were determined by flow cytometry.&#13;
&#13;
Results. Molecular criteria for the presence of precancerous pathology and cervical cancer have been found to be a 3.10 [1.31; 3.28] fold increase in SAA values (Ur-41.0, p=0.02), 2.62 [2.79 3.50] fold (U=137.0, p=0.001) in ICAM-1, 5.20 [3.84; 12.37] fold (U=138.5, p=0.001) in VCAM-1, and 4.32 [2.07; 5.02] fold (U=109.0, p</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/1591</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/1762</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
